Immediate Impact

1 by Nobel laureates 57 standout
Sub-graph 1 of 23

Citing Papers

Strategies to reduce the risks of mRNA drug and vaccine toxicity
2024 Standout
mRNA-based therapeutics: looking beyond COVID-19 vaccines
2024 StandoutNobel
1 intermediate paper

Works of Roberta Lemay being referenced

Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry disease
2015

Author Peers

Author Last Decade Papers Cites
Roberta Lemay 1358 404 607 444 15 1.4k
Anouk C. Vedder 1464 438 712 390 16 1.6k
Saskia M. Rombach 1500 455 745 352 34 1.8k
Marieke Biegstraaten 1090 313 403 273 29 1.2k
Makiko Yasuda 1124 372 558 488 42 2.0k
Alberto Ponzone 820 207 348 446 34 1.7k
Lewis Waber 874 125 370 280 19 1.6k
Maarten Arends 638 193 332 215 18 1.5k
Susanna Bunge 1002 274 552 285 26 1.2k
Rebecca S. Wappner 1198 431 548 162 36 2.1k
C. Ronald Scott 1115 405 449 106 20 1.5k

All Works

Loading papers...

Rankless by CCL
2026